RRC ID 10920
著者 Luo JC, Lin HY, Lu CL, Wang LY, Chang FY, Lin HC, Huang YC, Ng KM, Chi CW, Lee SD.
タイトル Dexamethasone inhibits basic fibroblast growth factor-stimulated gastric epithelial cell proliferation.
ジャーナル Biochem Pharmacol
Abstract Basic fibroblast growth factor (bFGF) is essential for gastric ulcer healing, whereas glucocorticoids delay gastric ulcer healing. We found that dexamethasone inhibited bFGF-stimulated rat gastric epithelial RGM-1 cells proliferation and attempted to elucidate the possible mechanistic pathway. Flowcytometry was used to determine cell proliferation. Western blot and RT-PCR were performed to evaluate changes in signaling pathways. Results showed that bFGF significantly increased mRNA expression of FGF receptor (FGFR)1 and FGFR2 at 10 min and increased expression of phosphorylated extracellular signal-regulated kinase (pERK1/pERK2) but not phosphorylated p38 mitogen-activated protein kinase (MAPK) or phosphorylated phosphatidylinositol 3-kinase (PI3K) within 30 min. This was followed by an increase of cyclooxygenase (COX)-2 mRNA and protein expression at 30 and 240 min, respectively. Mitogen-activated protein kinase kinase (MEK) inhibitor-PD98059 (10(-5) M) markedly suppressed bFGF-stimulated COX-2 expression and cell proliferation, but neither p38 MAPK inhibitor-SB203580 nor PI3K inhibitor-Wortmannin had any effect. Dexamethasone (10(-6)M) substantially reduced bFGF-stimulated ERK activation at 10 min, COX-2 mRNA and protein expression at 30 and 240 min, respectively, and prostaglandin E(2) synthesis at 8 h. Dexamethasone (10(-6) M) also significantly decreased mRNA expression of FGFR1 and FGFR2 at basal and bFGF-stimulated conditions at 10 min. This study indicated that bFGF-stimulated gastric epithelial RGM-1 cells proliferation via up-regulating FGFR1 and FGFR2, activating ERK1/ERK2 signal transduction pathway and COX-2 pathway. Dexamethasone significantly suppresses bFGF-stimulated RGM-1 cells proliferation in part via down-regulation of FGFR1/FGFR2, then decreasing bFGF-stimulated activation of ERK1/ERK2, followed by inhibition of COX-2 activation, and finally DNA synthesis.
巻・号 76(7)
ページ 841-9
公開日 2008-10-1
DOI 10.1016/j.bcp.2008.07.010
PII S0006-2952(08)00494-2
PMID 18692028
MeSH Animals Cell Line Cell Proliferation / drug effects* Cyclooxygenase 1 / genetics Cyclooxygenase 2 / genetics Cyclooxygenase 2 Inhibitors / pharmacology Dexamethasone / pharmacology* Dinoprostone / metabolism Epithelial Cells / cytology Epithelial Cells / drug effects* Fibroblast Growth Factor 2 / pharmacology* Gastric Mucosa / cytology* Humans Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors Mitogen-Activated Protein Kinase 1 / genetics Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors Mitogen-Activated Protein Kinase 3 / genetics RNA, Messenger / metabolism Rats Rats, Wistar Receptor, Fibroblast Growth Factor, Type 1 / antagonists & inhibitors Receptor, Fibroblast Growth Factor, Type 1 / genetics Receptor, Fibroblast Growth Factor, Type 2 / antagonists & inhibitors Receptor, Fibroblast Growth Factor, Type 2 / genetics Recombinant Proteins / pharmacology
IF 4.96
引用数 26
WOS 分野 PHARMACOLOGY & PHARMACY
リソース情報
ヒト・動物細胞 RGM1(RCB0876)